J. Goldman & CO LP Vincerx Pharma, Inc. Transaction History

J. Goldman & CO LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-43,101 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	43,101 New	43,101 $439,000
Q3 2021 Nov 15, 2021	SELL	$0.0 - $0.0 $0 - $0	-116,160 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $2.37 Million	87,603 Added 306.77%	116,160 $1.51 Million
Q1 2021 May 17, 2021	SELL	$22.6 - $31.0 $557,926 - $765,297	-24,687 Reduced 46.37%	28,557 $551,000
Q4 2020 Feb 16, 2021	BUY	$12.85 - $19.95 $684,185 - $1.06 Million	53,244 New	53,244 $1.11 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $3.18M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.